Q2 2019 Pieris Pharmaceuticals Inc Earnings Call Transcript
Good morning, and welcome to the Pieris Pharmaceuticals Second Quarter 2019 Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Allan Reine, CFO. Thank you, Mr. Reine, you may begin.
Good morning, everyone, and thank you for joining us for our second quarter 2019 conference call and corporate update.
On the call today, we have Steve Yoder, our President and CEO; and Lou Matis, SVP and Chief Development Officer, who will be available for Q&A. You can access the press release this morning on the Investor Relations page of our website at www.pieris.com.
Before we begin, I'd like to caution that comments made during this conference call may contain forward-looking statements involving risks and uncertainties regarding the operations and future results of operations of Pieris, including statements relating to the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |